Evaluation of efficacy and safety of lubiprostone in patients with chronic constipation

References

• Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99(4):750–759.
   PubMed Web of Science ®Google Scholar
• Belsey J, Greenfield S, Candy D, et al. Systematic review: impact of constipation on quality of life in adults and children. Aliment Pharmacol Ther. 2010;31(9):938–949.
   PubMed Web of Science ®Google Scholar
• Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–1491.
   PubMed Web of Science ®Google Scholar
• Harris LA. Prevalence and ramifications of chronic constipation. Manag Care Interface. 2005;18(8):23–30.
   PubMedGoogle Scholar
• De Giorgio R, Ruggeri E, Stanghellini V, et al. Chronic constipation in the elderly: a primer for the gastroenterologist. BMC Gastroenterol. 2015;15:130.
   PubMed Web of Science ®Google Scholar
• Salive ME. Multimorbidity in older adults. Epidemiol Rev. 2013;35:75–83.
   PubMed Web of Science ®Google Scholar
• Whitehead WE, Drinkwater D, Cheskin LJ, et al. Constipation in the elderly living at home. Definition, prevalence, and relationship to lifestyle and health status. J Am Geriatr Soc. 1989;37(5):423–429.
   PubMed Web of Science ®Google Scholar
• Johanson JF, Sonnenberg A, Koch TR. Clinical epidemiology of chronic constipation. J Clin Gastroenterol. 1989;11(5):525–536.
   PubMed Web of Science ®Google Scholar
• Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100(4):936–971.
   PubMed Web of Science ®Google Scholar
• Johanson JF, Morton D, Geenen J, et al. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol. 2008;103(1):170–177.
   PubMed Web of Science ®Google Scholar
• Barish CF, Drossman D, Johanson JF, et al. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci. 2010;55(4):1090–1097.
   PubMed Web of Science ®Google Scholar
• Fukudo S, Hongo M, Kaneko H, et al. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol. 2015;13(2):294–301.e5.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Bharucha AE, Ueno R, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006;290(5):G942–7.
   PubMed Web of Science ®Google Scholar
• Johanson JF, Drossman DA, Panas R, et al. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2008;27(8):685–696.
   PubMed Web of Science ®Google Scholar
• Drossman DA, Chey WD, Johanson JF, et al. Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome-results of two randomized, placebo-controlled studies. Aliment Pharmacol Ther. 2009;29(3):329–341.
   PubMed Web of Science ®Google Scholar
• Cryer B, Drossman DA, Chey WD, et al. Analysis of nausea in clinical studies of lubiprostone for the treatment of constipation disorders. Dig Dis Sci. 2017;62(12):3568–3578.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Osumi S, Yanagisawa D, et al. Possible effect of concomitant prokinetics and herbal medicines against nausea in patients taking lubiprostone. Biomed Res Int. 2017;2017:3762179.
   PubMed Web of Science ®Google Scholar
• D'Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265–2281.
   PubMed Web of Science ®Google Scholar
• Chan WW, Mashimo H. Lubiprostone increases small intestinal smooth muscle contractions through a prostaglandin E receptor 1 (EP1)-mediated pathway. J Neurogastroenterol Motil. 2013;19(3):312–318.
   PubMed Web of Science ®Google Scholar
• Preston DM, Lennard-Jones JE. Severe chronic constipation of young women: ‘idiopathic slow transit constipation’. Gut. 1986; 27(1):41–48.
   PubMed Web of Science ®Google Scholar
• Pare P, Ferrazzi S, Thompson WG, et al. An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking. Am J Gastroenterology. 2001;96(11):3130–3137.
   PubMed Web of Science ®Google Scholar
• Choung RS, Locke GR, Schleck CD, Zinsmeister AR, et al. Cumulative incidence of chronic constipation: a population-based study 1988–2003. Aliment Pharmacol Ther. 2007;26(11–12):1521–1528.
   PubMed Web of Science ®Google Scholar
• McCrea GL, Miaskowski C, Stotts NA, et al. A review of the literature on gender and age differences in the prevalence and characteristics of constipation in North America. J Pain Symptom Manage. 2009;37(4):737–745.
   PubMed Web of Science ®Google Scholar
• Kepenekci I, Keskinkilic B, Akinsu F, et al. Prevalence of pelvic floor disorders in the female population and the impact of age, mode of delivery, and parity. Dis Colon Rectum. 2011;54(1):85–94.
   PubMed Web of Science ®Google Scholar
• Kurniawan I, Simadibrata M. Management of chronic constipation in the elderly. Acta Med Indones. 2011;43(3):195–205.
   PubMedGoogle Scholar
• Sweetser S, Busciglio IA, Camilleri M, et al. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2009;296(2):G295–G301.
   PubMed Web of Science ®Google Scholar
• Lunsford TN, Harris LA. Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome. Int J Womens Health. 2010;2:361–374.
   PubMedGoogle Scholar
• Chamberlain SM, Rao SSC. Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome. Expert Opin Drug Saf. 2012;11(5):841–850.
   PubMed Web of Science ®Google Scholar
• Fisher JP, Paton JF. The sympathetic nervous system and blood pressure in humans: implications for hypertension. J Hum Hypertens. 2012;26(8):463–475.
   PubMed Web of Science ®Google Scholar
• McCorry LK. Physiology of the autonomic nervous system. Am J Pharm Educ. 2007;71(4):78.
   PubMed Web of Science ®Google Scholar
• Singh P, Yoon SS, Kuo B. Nausea: a review of pathophysiology and therapeutics. Therap Adv Gastroenterol. 2016;9(1):98–112.
   PubMed Web of Science ®Google Scholar